After skin cancer, prostate cancer is one of the most common cancers among the males in the U.S. Men around 65-70 years of age are more likely to get affected by prostate cancer, said the studies.
European trial study of screening showed that screening of PSA has brought down the rate of deaths due to prostate cancer by 20%.
A new research published by Annals of Internal Medicine shows that men above 55 years of age, if screened for PSA, the chances of death due to prostate cancer can be reduced.
Studies also show that if men in the age bracket of 55-70 year should get PSA screening done, the death rate due to prostate cancer can be reduced by 25-30 percent.
However, there are chances of over-treating a patient, which might have adverse effects on him. So, it has been said that the decision about PSA screening would be an individual’s choice after consulting their respective doctors.
Prostate cancer surgery can affect the quality of a man’s sex life by affecting their impotence. On the other hand, most prostate cancers grow slowly and men suffering from prostate cancer are likely to die of heart disease.
In 2009, there was a clinical trial taken by the U.S and one from Europe. Unfortunately, these trials created more confusion rather than providing clarity on this issue.
As there are pros and cons for everything we take up in this world, the decision of going through PSA screening is left to the individuals.